1. Home
  2. DNLI vs PARR Comparison

DNLI vs PARR Comparison

Compare DNLI & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$18.42

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo Par Pacific Holdings Inc.

PARR

Par Pacific Holdings Inc.

N/A

Current Price

$63.51

Market Cap

3.4B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
DNLI
PARR
Founded
2013
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Integrated oil Companies
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
DNLI
PARR
Price
$18.42
$63.51
Analyst Decision
Strong Buy
Buy
Analyst Count
21
8
Target Price
$35.82
★ $94.38
AVG Volume (30 Days)
★ 1.3M
765.8K
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1313.56
EPS
N/A
★ 17.54
Revenue
N/A
★ $2,443,066,000.00
Revenue This Year
N/A
$42.03
Revenue Next Year
$204.90
N/A
P/E Ratio
★ N/A
$3.67
Revenue Growth
N/A
★ 30.99
52 Week Low
$15.34
$34.37
52 Week High
$27.30
$90.74

Technical Indicators

Market Signals
Indicator
DNLI
PARR
Relative Strength Index (RSI) 43.32 33.13
Support Level $18.24 $55.45
Resistance Level $21.45 $68.89
Average True Range (ATR) 0.94 3.52
MACD -0.10 -0.43
Stochastic Oscillator 24.50 2.75

Price Performance

Historical Comparison
DNLI
PARR

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

About PARR Par Pacific Holdings Inc.

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

Share on Social Networks: